- Targeted stakeholdersRaises public awareness of Parkinson’s disease and its symptoms, potentially improving early detection and referral.
- Targeted stakeholdersEncourages additional private and philanthropic fundraising and volunteer engagement for Parkinson’s research and suppo…
- Targeted stakeholdersIncreases advocacy pressure on lawmakers and agencies to prioritize research funding and supportive programs.
Expressing support for the designation of the month of April 2026 as "Parkinson's Awareness Month".
Referred to the House Committee on Energy and Commerce.
This House resolution expresses support for designating April 2026 as "Parkinson’s Awareness Month." It cites prevalence, projected growth, economic and caregiving burdens, and calls for more research, education, community support, and recognition of clinical trial participants and advocates.
The resolution is nonbinding and symbolic, commending organizations and individuals working on Parkinson’s disease.
Cannot become law as a House simple resolution; adoption by the House is likely but it does not create binding law.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly states the purpose and reasons for designating April 2026 as Parkinson’s Awareness Month. It uses an appropriate, minimal structure for a symbolic expression of support.
Liberal emphasizes using designation to push federal research and caregiver funding
Who stands to gain, and who may push back.
- Targeted stakeholdersCreates only symbolic recognition with no direct funding or enforceable policy changes.
- Targeted stakeholdersMay divert nonprofit resources toward awareness events instead of direct services or research programs.
- Targeted stakeholdersProvides limited measurable impact on jobs, tax revenue, or regulatory burdens.
Why the argument around this bill splits.
Liberal emphasizes using designation to push federal research and caregiver funding
Likely strongly supportive as a compassionate, public-health–oriented measure that raises awareness and legitimizes calls for increased research and caregiver supports.
Would view the resolution as an opportunity to push for expanded federal research funding and social supports, though it contains no appropriations itself.
Generally supportive, viewing it as a low‑cost, bipartisan acknowledgment of a growing public‑health issue.
Sees value in awareness but wants clarity that it does not create unfunded mandates or hidden costs, and would favor measurable follow‑on actions.
Likely broadly supportive as a nonbinding, compassionate recognition of patients and caregivers, while remaining wary of using this as justification for expanded federal spending.
Prefers private‑sector and state solutions for any new programs.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Cannot become law as a House simple resolution; adoption by the House is likely but it does not create binding law.
- Whether the House will consider it under suspension or in committee
- Existence or filing of a companion Senate resolution
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberal emphasizes using designation to push federal research and caregiver funding
Cannot become law as a House simple resolution; adoption by the House is likely but it does not create binding law.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly states the purpose and reasons for designating April 2026 as Parkinson’s Awareness Month. It uses an approp…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.